Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

NCT00806858 · clinicaltrials.gov ↗

COMPLETED

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Delivery Systems

Interventions

DEVICE: NovoPen® 4

Sponsor

Novo Nordisk A/S